Blood thinner bivalirudin is more effective than heparin with optional use of glycoprotein IIb/IIIa inhibitors in reducing risk of death and major bleeding complications in patients with ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) in a pre-hospital setting, a new study reveals. Findings from the EUROMAX trial were reported today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored ...
Read MoreYou have just read an article categorized health
titled Pre-Hospital Administration of Bivalirudin More Effective Than Heparin in Reducing Mortality Risk Among Heart Attack Patients.
Written by:
editor - Sunday, November 3, 2013
There are currently no comments for "Pre-Hospital Administration of Bivalirudin More Effective Than Heparin in Reducing Mortality Risk Among Heart Attack Patients"
Post a Comment